Successful Control of Massive Bleeding in a Child with Burkitt's Lymphoma via a Biosimilar Recombinant Activated Factor VII (AryoSeven™)

We describe a case of a 4-year-old girl with Burkitt's lymphoma, who suffered from a massive gastrointestinal hemorrhage 3 days after chemotherapy. In spite of applying the common practice in correction of coagulopathy, thrombocytopenia persisted and bleeding became life-threatening. In the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Goudarzi Pour, Kourosh, Malek, Fatemeh, Eshghi, Peyman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958449/
https://www.ncbi.nlm.nih.gov/pubmed/27478659
http://dx.doi.org/10.1155/2016/1295092
_version_ 1782444312684920832
author Goudarzi Pour, Kourosh
Malek, Fatemeh
Eshghi, Peyman
author_facet Goudarzi Pour, Kourosh
Malek, Fatemeh
Eshghi, Peyman
author_sort Goudarzi Pour, Kourosh
collection PubMed
description We describe a case of a 4-year-old girl with Burkitt's lymphoma, who suffered from a massive gastrointestinal hemorrhage 3 days after chemotherapy. In spite of applying the common practice in correction of coagulopathy, thrombocytopenia persisted and bleeding became life-threatening. In the present case report, we report a successful control of bleeding with a single-dose administration of a biosimilar recombinant activated human factor VII (AryoSeven).
format Online
Article
Text
id pubmed-4958449
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-49584492016-07-31 Successful Control of Massive Bleeding in a Child with Burkitt's Lymphoma via a Biosimilar Recombinant Activated Factor VII (AryoSeven™) Goudarzi Pour, Kourosh Malek, Fatemeh Eshghi, Peyman Case Rep Hematol Case Report We describe a case of a 4-year-old girl with Burkitt's lymphoma, who suffered from a massive gastrointestinal hemorrhage 3 days after chemotherapy. In spite of applying the common practice in correction of coagulopathy, thrombocytopenia persisted and bleeding became life-threatening. In the present case report, we report a successful control of bleeding with a single-dose administration of a biosimilar recombinant activated human factor VII (AryoSeven). Hindawi Publishing Corporation 2016 2016-07-10 /pmc/articles/PMC4958449/ /pubmed/27478659 http://dx.doi.org/10.1155/2016/1295092 Text en Copyright © 2016 Kourosh Goudarzi Pour et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Goudarzi Pour, Kourosh
Malek, Fatemeh
Eshghi, Peyman
Successful Control of Massive Bleeding in a Child with Burkitt's Lymphoma via a Biosimilar Recombinant Activated Factor VII (AryoSeven™)
title Successful Control of Massive Bleeding in a Child with Burkitt's Lymphoma via a Biosimilar Recombinant Activated Factor VII (AryoSeven™)
title_full Successful Control of Massive Bleeding in a Child with Burkitt's Lymphoma via a Biosimilar Recombinant Activated Factor VII (AryoSeven™)
title_fullStr Successful Control of Massive Bleeding in a Child with Burkitt's Lymphoma via a Biosimilar Recombinant Activated Factor VII (AryoSeven™)
title_full_unstemmed Successful Control of Massive Bleeding in a Child with Burkitt's Lymphoma via a Biosimilar Recombinant Activated Factor VII (AryoSeven™)
title_short Successful Control of Massive Bleeding in a Child with Burkitt's Lymphoma via a Biosimilar Recombinant Activated Factor VII (AryoSeven™)
title_sort successful control of massive bleeding in a child with burkitt's lymphoma via a biosimilar recombinant activated factor vii (aryoseven™)
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958449/
https://www.ncbi.nlm.nih.gov/pubmed/27478659
http://dx.doi.org/10.1155/2016/1295092
work_keys_str_mv AT goudarzipourkourosh successfulcontrolofmassivebleedinginachildwithburkittslymphomaviaabiosimilarrecombinantactivatedfactorviiaryoseven
AT malekfatemeh successfulcontrolofmassivebleedinginachildwithburkittslymphomaviaabiosimilarrecombinantactivatedfactorviiaryoseven
AT eshghipeyman successfulcontrolofmassivebleedinginachildwithburkittslymphomaviaabiosimilarrecombinantactivatedfactorviiaryoseven

Ejemplares similares